Search research articles
Contact Us
Filters
Showing results (221-230 of 239) with videos related to
Page
of 24
Sort By:
Scientific Reports
|
December 19, 2019
Characterization of multi-channel intraneural stimulation in transradial amputees
I Strauss, G Valle, F Artoni, et al.
Bone Marrow Transplantation
|
April 30, 2002
The role of molecular monitoring in autotransplantation for non-Hodgkin's lymphoma
S Galimberti, R Marasca, F Caracciolo, et al.
Scientific Reports
|
November 14, 2018
Comparison of linear frequency and amplitude modulation for intraneural sensory feedback in bidirectional hand prostheses
G Valle, F M Petrini, I Strauss, et al.
Oncogene
|
October 6, 2015
AP2α controls the dynamic balance between miR-126&126* and miR-221&222 during melanoma progression
N Felli, M C Errico, F Pedini, et al.
Haematologica
|
May 18, 1999
Clinical characteristics, treatment outcome and survival of 36 adult patients with primary anaplastic large cell lymphoma. Gruppo Italiano per lo Studio dei Linfomi (GISL)
G Longo, C Fiorani, S Sacchi, et al.
Nanotechnology
|
December 7, 2016
Gold nanoparticles as scaffolds for poor water soluble and difficult to vehiculate antiparkinson codrugs
A Di Crescenzo, I Cacciatore, M Petrini, et al.
Leukemia Research
|
July 17, 2007
PS-341 (Bortezomib) inhibits proliferation and induces apoptosis of megakaryoblastic MO7-e cells
S Galimberti, M Canestraro, S Pacini, et al.
British Journal of Cancer
|
March 1, 1996
Experience with poorly myelosuppressive chemotherapy schedules for advanced myeloma. The Cooperative Group of Study and Treatment of Multiple Myeloma
S Brugnatelli, A Riccardi, G Ucci, et al.
Journal of Chemotherapy (Florence, Italy)
|
June 28, 2007
The efficacy of rituximab plus Hyper-CVAD regimen in mantle cell lymphoma is independent of FCgammaRIIIa and FCgammaRIIa polymorphisms
S Galimberti, G A Palumbo, F Caracciolo, et al.
The Pharmacogenomics Journal
|
March 5, 2014
The c.480C>G polymorphism of hOCT1 influences imatinib clearance in patients affected by chronic myeloid leukemia
A Di Paolo, M Polillo, M Capecchi, et al.
Page
of 24
Search research articles
Search
Showing results (221-230 of 239) with videos related to
Sort By:
Page
of 24
Scientific Reports
|
December 19, 2019
Characterization of multi-channel intraneural stimulation in transradial amputees
I Strauss, G Valle, F Artoni, et al.
Bone Marrow Transplantation
|
April 30, 2002
The role of molecular monitoring in autotransplantation for non-Hodgkin's lymphoma
S Galimberti, R Marasca, F Caracciolo, et al.
Scientific Reports
|
November 14, 2018
Comparison of linear frequency and amplitude modulation for intraneural sensory feedback in bidirectional hand prostheses
G Valle, F M Petrini, I Strauss, et al.
Oncogene
|
October 6, 2015
AP2α controls the dynamic balance between miR-126&126* and miR-221&222 during melanoma progression
N Felli, M C Errico, F Pedini, et al.
Haematologica
|
May 18, 1999
Clinical characteristics, treatment outcome and survival of 36 adult patients with primary anaplastic large cell lymphoma. Gruppo Italiano per lo Studio dei Linfomi (GISL)
G Longo, C Fiorani, S Sacchi, et al.
Nanotechnology
|
December 7, 2016
Gold nanoparticles as scaffolds for poor water soluble and difficult to vehiculate antiparkinson codrugs
A Di Crescenzo, I Cacciatore, M Petrini, et al.
Leukemia Research
|
July 17, 2007
PS-341 (Bortezomib) inhibits proliferation and induces apoptosis of megakaryoblastic MO7-e cells
S Galimberti, M Canestraro, S Pacini, et al.
British Journal of Cancer
|
March 1, 1996
Experience with poorly myelosuppressive chemotherapy schedules for advanced myeloma. The Cooperative Group of Study and Treatment of Multiple Myeloma
S Brugnatelli, A Riccardi, G Ucci, et al.
Journal of Chemotherapy (Florence, Italy)
|
June 28, 2007
The efficacy of rituximab plus Hyper-CVAD regimen in mantle cell lymphoma is independent of FCgammaRIIIa and FCgammaRIIa polymorphisms
S Galimberti, G A Palumbo, F Caracciolo, et al.
The Pharmacogenomics Journal
|
March 5, 2014
The c.480C>G polymorphism of hOCT1 influences imatinib clearance in patients affected by chronic myeloid leukemia
A Di Paolo, M Polillo, M Capecchi, et al.
Page
of 24